Patient Square Capital LP
Patient Square Capital LP is a purpose-built, healthcare-focused investment firm headquartered in Menlo Park, California, United States. Founded in 2020, the firm partners with management teams whose products, services, and technologies improve health. The firm comprises a team of seasoned industry executives and investors with approximately 77 employees as of March 2025. Patient Square Capital serves institutional investors, management teams, and portfolio companies across the healthcare sector.
Investment Strategy
Patient Square Capital employs a focused, patient-centric investment approach within the healthcare sector. The firm leverages deep industry expertise, a broad network of relationships, and a true partnership model to invest in companies poised for long-term growth. Prioritizing companies improving patient lives, the firm seeks to drive value through operational excellence, growth initiatives, and strategic partnerships, always keeping patients at the center of their decision-making process.
Latest 13F Filing Activity
Patient Square Capital LP filed their most recent 13F report on Jun 30, 2025 disclosing 19 equity positions with a total 13F market value of $277M. The fund increased holdings in Argenx SE - Adr, Roivant Sciences LTD., Insmed Inc. among other positions. Patient Square Capital LP reduced exposure to Liquidia Corporation, Blueprint Medicines Corporation, Intellia Therapeutics, Inc. among others.
Top Holdings
Equity Positions (19)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
R ROIV | ROIVANT SCIENCES LTD. | 50.71% | $140.6M | 12,480,000 | $9.01 | $11.27 | +$14.7M |
I INSM | INSMED INC | 13.02% | $36.1M | 358,800 | $73.92 | $100.64 | +$10.9M |
A ARGX | ARGENX SE - ADR | 5.76% | $16.0M | 29,000 | $551.22 | $551.22 | +$16.0M |
E EYPT | EYEPOINT PHARMACEUTICALS, INC. | 4.59% | $12.7M | 1,352,837 | $7.85 | $9.41 | +$4.7M |
L LQDA | LIQUIDIA CORPORATION | 4.58% | $12.7M | 1,020,000 | $14.92 | $12.46 | -$9.7M |
Industry Allocation
Investment Team (15)
| Name | Role | Location | |
|---|---|---|---|
 | Principal | CA , United States | |
J Justin Sabet-Peyman | Partner | United States | |
 | Principal | Stanford, CA , United States | |
U Usman Baig | Private Equity | San Francisco, CA , United States | |
 | Partner | New York, NY , United States | |
F Fielden Baker | Private Equity Associate | CA , United States | |
G Gourab Banerjee | Senior Research Associate | New York, NY , United States | |
 | Partner | San Francisco, CA , United States | |
 | Associate | Menlo Park, CA , United States | |
P Patrick Martin | Principal | United States |